Ashwin Ananthakrishnan, MD
Articles
Weighing the Benefits of Combination Therapy in Crohn's Disease
March 10th 2014Recent studies suggest that combination therapy with infliximab and azathioprine is more effective than monotherapy in patients with newly diagnosed Crohn's disease, but patients with more established Crohn's disease do not derive any extra benefit from triple therapy with infliximab, methotrexate, and prednisone compared to double therapy with infliximab and prednisone.
Read More
Latest Updated Articles
Published: October 4th 2024 | Updated: October 14th 2024
Minimally Invasive Techniques to Manage Complex Polyps at Allegheny Health Network
Published: May 2nd 2024 | Updated: May 6th 2024
Cardiology Month in Review: April 2024
Published: November 16th 2024 | Updated: December 22nd 2024
Hide Okuno, MS: Tube Weaning Reduces Parental Stress, Findings Guide Future Studies
Published: November 15th 2024 | Updated: December 22nd 2024
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Published: December 16th 2024 | Updated: December 22nd 2024
Brilaroxazine Shows Long-Term Efficacy in Schizophrenia in Phase 3 RECOVER
Published: December 16th 2024 | Updated: December 22nd 2024
FDA Approves Tapinarof 1% Cream for Adult, Pediatric Patients with Atopic Dermatitis
